Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China
· Delayed Price · Currency is CNY 18.65
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST
SHE:300482 Revenue
Guangzhou Wondfo Biotech Co.,Ltd had revenue of 581.74M CNY in the quarter ending March 31, 2026, a decrease of -27.31%. This brings the company's revenue in the last twelve months to 1.87B, down -37.81% year-over-year. In the year 2025, Guangzhou Wondfo Biotech Co.,Ltd had annual revenue of 2.09B, down -31.91%.
Revenue (ttm)
1.87B
Revenue Growth
-37.81%
P/S Ratio
4.64
Revenue / Employee
584.39K
Employees
3,197
Market Cap
8.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.09B | -977.98M | -31.91% |
| Dec 31, 2024 | 3.06B | 299.90M | 10.85% |
| Dec 31, 2023 | 2.76B | -2.92B | -51.33% |
| Jan 1, 2023 | 5.68B | 2.32B | 69.01% |
| Dec 31, 2021 | 3.36B | 550.20M | 19.57% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Edan Instruments | 2.09B |
| Sino Medical Sciences Technology | 525.41M |
| HOB Biotech Group Corp.,Ltd | 398.40M |
| INKON Life Technology | 1.97B |
| Xiangyu Medical Co.,Ltd | 774.78M |
| Shinva Medical Instrument | 9.58B |
| Shenzhen YHLO Biotech | 1.81B |
| Sinocare | 4.86B |